These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11077979)

  • 1. Effect of hypertension on the development of diabetic cardiomyopathy.
    Mathis DR; Liu SS; Rodrigues BB; McNeill JH
    Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration.
    Dai S; Lee S; Battell M; McNeill JH
    Can J Cardiol; 1994 Jun; 10(5):562-70. PubMed ID: 8012888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
    Iwase M
    Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes.
    Wold LE; Relling DP; Colligan PB; Scott GI; Hintz KK; Ren BH; Epstein PN; Ren J
    J Mol Cell Cardiol; 2001 Sep; 33(9):1719-26. PubMed ID: 11549350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
    Hakim ZS; Goyal RK
    Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.
    Yousif MH; Akhtar S; Walther T; Benter IF
    Cell Biochem Funct; 2008; 26(2):256-63. PubMed ID: 18035860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin.
    Jian K; Fok E; Cam MC; Sambandam N; Yao J; Rodrigues B
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1215-21. PubMed ID: 9028580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes.
    Goyal BR; Solanki N; Goyal RK; Mehta AA
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometrical and biochemical differences of endocrine pancreata between spontaneously hypertensive and normotensive rats with or without neonatal streptozotocin-induced diabetes.
    Iwase M; Nunoi K; Kikuchi M; Maki Y; Kodama T; Sadoshima S; Fujishima M
    Lab Invest; 1989 Jan; 60(1):102-5. PubMed ID: 2521365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR; Gabra BH; Nantel F; Battistini B; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):69-78. PubMed ID: 15878326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered inotropic responses in diabetic cardiomyopathy and hypertensive-diabetic cardiomyopathy.
    Yu Z; McNeill JH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):64-71. PubMed ID: 1708426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
    Udayachalerm W; Vechakarn O; Patumraj S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma prekallikrein activity, blood pressure, and left ventricular thickness in hypertensive and normotensive diabetic rats.
    Sharma JN; Kesavarao U
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):75-8. PubMed ID: 17440623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ras-GTPase signaling by FPTIII ameliorates development of cardiovascular dysfunction in diabetic-hypertensive rats.
    Yousif MH; Benter IF; Abul AH; Abraham S; Walther T; Akhtar S
    Vascul Pharmacol; 2008; 49(4-6):151-7. PubMed ID: 18706523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR).
    Swislocki A; Burgie ES; Rodnick KJ
    Horm Metab Res; 2002 Sep; 34(9):516-22. PubMed ID: 12384829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV; Goyal RK
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.
    El-Helou V; Proulx C; Béguin P; Assimakopoulos J; Gosselin H; Clement R; Villeneuve L; Huot-Marchand JE; Deblois D; Lajoie C; Calderone A
    J Cell Physiol; 2009 Aug; 220(2):440-9. PubMed ID: 19388005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.